Mundipharma Research Limited
Clinical trials sponsored by Mundipharma Research Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for rare lung infection: weekly drug shows promise in early trial Results expected Nov 2026 (estimated)
-
New hope for glioblastoma? early trial tests tinostamustine
Disease control CompletedThis early-phase study tested a new drug called tinostamustine in 10 people with a specific type of glioblastoma, a severe brain cancer. The drug was given after standard treatment to see if it is safe and to find the right dose. The goal is to control the disease and delay its r…
Early phase 1 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug could shield transplant patients from deadly fungal infections
Prevention CompletedThis study tested a new medicine called rezafungin to see if it can prevent serious fungal infections in adults getting a bone marrow transplant. About 600 participants received either rezafungin or the standard treatment. The goal was to see if rezafungin helps more people stay …
Phase 3 • Sponsor: Mundipharma Research Limited • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC